PharmaTher Secures Japanese Patent For Ketabet
PharmaTher Holdings (CSE: PHRM) announced today that it has been granted a Japanese patent for its ketamine combination formulation, Ketabet. The
Read more
Pharmather
PharmaTher To Raise $10.0 Million Via Institutional Investor Financing
PharmaTher Holdings (CSE: PHRM) this morning indicated that the company has secured a financing with institutional investors. The firm will
Read more
PharmaTher: Maxim Initiates Coverage With US$1.50 Price Target
PharmaTher Holdings (CSE: PHRM) had its first initiation report that came out on June 28th. Maxim Group initiated coverage on
Read more
PharmaTher Applies For Pre-IND Meeting With US FDA For Ketabet
PharmaTher Holdings (CSE: PHRM) this morning announced that it continues to push forward with the development of Ketabet. The company
Read more
PharmaTher Partners With TSRL For Microneedle Patch Development
PharmaTher Holdings (CSE: PHRM) has partnered with that of TSRL under a co-development agreement. The arrangement will see the two
Read more
PharmaTher Files With FDA For Orphan Drug Designation In Use Of Ketamine For ALS
PharmaTher Holdings (CSE: PHRM) this morning announced that it has filed with the US FDA for orphan drug designation as
Read more
PharmaTher Receives FDA Approval For Ketamine Trial For Parkinson’s
PharmaTher Holdings (CSE: PHRM) has seen the US FDA approve the firms application for an investigational new drug. The approval
Read more
PharmaTher Files Patent For Use Of Ketamine In Type 2 Diabetes, Obesity
PharmaTher Holdings (CSE: PHRM) has expanded its patent portfolio. The company this morning announced the filing of a provisional patent
Read more
PharmaTher Submits For Phase 2 Clinical Trial With FDA
PharmaTher Holdings (CSE: PHRM) is looked to complete a phase two clinical trial. The company this morning announced the submittal
Read more
PharmaTher Sponsors Research For Novel Delivery Of Ketamine
PharmaTher Inc (CSE: PHRM) this morning announced that it has entered into a sponsored research agreement. The agreement, which was
Read more